The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Feb. 26, 2019
Filed:
Aug. 07, 2015
Applicant:
Nitto Boseki Co., Ltd., Fukushima-shi, JP;
Inventors:
Assignee:
NITTO BOSEKI CO., LTD., Fukushima-shi, JP;
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
C07K 16/00 (2006.01); C12P 21/08 (2006.01); C12Q 1/00 (2006.01); C12N 5/07 (2010.01); C12N 5/16 (2006.01); C07K 16/40 (2006.01); C12N 15/00 (2006.01); C12N 15/02 (2006.01); G01N 33/53 (2006.01); G01N 33/543 (2006.01); G01N 33/545 (2006.01); G01N 33/553 (2006.01); G01N 33/577 (2006.01); G01N 33/573 (2006.01); C12N 5/12 (2006.01); C07K 16/18 (2006.01); A61K 39/00 (2006.01); G01N 33/50 (2006.01); C07K 16/30 (2006.01); A61K 38/00 (2006.01); C12N 9/16 (2006.01);
U.S. Cl.
CPC ...
C07K 16/40 (2013.01); C12N 5/12 (2013.01); C12N 5/163 (2013.01); C12N 15/00 (2013.01); C12N 15/02 (2013.01); C12Y 301/03002 (2013.01); G01N 33/53 (2013.01); G01N 33/543 (2013.01); G01N 33/545 (2013.01); G01N 33/553 (2013.01); G01N 33/573 (2013.01); G01N 33/577 (2013.01); A61K 38/00 (2013.01); A61K 2039/505 (2013.01); C07K 16/18 (2013.01); C07K 16/30 (2013.01); C07K 2317/14 (2013.01); C07K 2317/33 (2013.01); C12N 9/16 (2013.01); G01N 33/5008 (2013.01); G01N 2333/916 (2013.01); G01N 2800/10 (2013.01);
Abstract
The purpose of the present invention is to provide a monoclonal antibody that is useful in specifically assaying tartrate resistant acid phosphatase 5b (TRACP-5b). A hybridoma producing a monoclonal antibody against TRACP-5b, said monoclonal antibody showing higher reactivity with TRACP-5b than with tartrate resistant acid phosphatase 5a (TRACP-5a) and, therefore, being specific to TRACP-5b, is obtained by cell fusion using, as an antigen, human recombinant TRACP-5b purified from silkworm silk gland. By using this monoclonal antibody, TRACP-5b in a specimen can be highly sensitively and specifically detected.